FDA Inspection 1210838 — Taiwan Shuenn-An Biotechnology Pharmaceutical Co., Ltd
The FDA completed an inspection of Taiwan Shuenn-An Biotechnology Pharmaceutical Co., Ltd on Jun 16, 2023 in Gao Xiong Shi. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jun 16, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Gao Xiong Shi (Taiwan)